Biocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
Biocon Pharma is recalling 2,184 bottles of Atorvastatin Calcium Tablets USP 40 mg nationwide. The product failed to meet required dissolution specifications, which may affect medication absorption.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall due to failed dissolution specifications that could impact proper medication absorption. No illnesses or injuries have been reported. Classified as High because the manufacturing defect creates a risk of harm through compromised therapeutic efficacy, even though no confirmed adverse events have been documented.
Plain-English summary
Biocon Pharma Inc. is recalling Atorvastatin Calcium Tablets USP 40 mg in 1,000-count bottles. The affected product was manufactured by Recipharm Pharmaservices PVT, Ltd in Bengaluru, India, and distributed nationwide in the United States. The recall affects 2,184 bottles with Lot Number AVC24035 and expiration date March 31, 2026, with NDC 70377-079-13.
The recall was initiated because the product failed to meet required dissolution specifications. Dissolution is the rate at which a tablet breaks down and releases its active ingredient. When dissolution specifications are not met, the medication may not be properly absorbed in the body.
Patients currently taking this medication should check with their pharmacy to determine whether they have received product from the affected lot. Patients should not discontinue their medication without consulting their healthcare provider. Those with product from the affected lot should discuss options with their pharmacy for obtaining alternate product.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- BIOCON PHARMA INC
- Category
- Drug — Prescription / Statin
- Hazard
- failed-dissolution
- bioavailability-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: AVC24035
- Exp 03/31/26
UPCs (1)
- 0370377080111
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium tablets recalled nationwide for failed dissolution specifications
FDA (Drugs) · 2025-10-22
- HighAtorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium Tablets Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- HighPrescription atorvastatin bottles recalled for containing wrong medication
FDA (Drugs) · 2024-10-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27